510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K182692Substantially Equivalent

BD MAX CTGCTV2, BD MAX System

Becton Dickinson & Co, Sparks MD / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K182692 is the FDA 510(k) clearance record for BD MAX CTGCTV2, BD MAX System, a class II device, cleared for Becton, Dickinson and Company on under FDA product code OUY (Trichomonas Vaginalis Nucleic Acid Amplification Test System). FDA's definition for product code OUY reads: "In vitro nucleic acid amplification test for the qualitative detection of ribosomal rna from trichomonas vaginalis as an aid in the diagnosis of trichomoniasis from vaginal, cervical, urogenital and gynecological specimens from symptomatic...". FDA records list 345 510(k) clearances for Becton, Dickinson and Company, from to . As of , FDA records show no recalls naming K182692.

Clearance record

Decision date
Received
(103 days to decision)
Product code
OUY Trichomonas Vaginalis Nucleic Acid Amplification Test System
Regulation
21 CFR 866.3860
Device class
Class II
Review panel
Immunology
Applicant
Becton, Dickinson and Company 7loveton Cir., Sparks MD
510(k) summary
Summary PDF
Third party review
No

Clearances, product code OUY

Trailing 12 months

FDA records hold no clearances under product code OUY in the trailing twelve months.

FDA records show no clearances under product code OUY in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code OUY, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260